Advanced search
Publication Cover
Current Medical Research and Opinion Volume 17, 2001 - Issue sup1
Submit an article Journal homepage
38
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Acute Treatments: Some Blind Alleys

Nabih M. Ramadan Eli Lilly & Co. and Indiana University School of Medicine, Indianapolis, Indiana, USACorrespondence[email protected]
Pages s71-80 | Published online: 29 Aug 2008

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andrea Negro, Angela Koverech & Paolo Martelletti. (2018) Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential. Journal of Pain Research 11, pages 515-526.
Read now
Fred D Sheftell, Marcelo E Bigal, Stewart J Tepper & Alan M Rapoport. (2004) Sumatriptan: a decade of use and experience in the treatment of migraine. Expert Review of Neurotherapeutics 4:2, pages 199-209.
Read now

Articles from other publishers (5)

Min Hou, Haiyan Xing, Chen Li, Xianfeng Wang, Dongmei Deng, Juan Li, Pan Zhang & Jianhong Chen. (2020) Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis. The Journal of Headache and Pain 21:1.
Crossref
YW Woldeamanuel, AM Rapoport & RP Cowan. (2015) The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal. Cephalalgia 35:11, pages 996-1024.
Crossref
Y. W. Woldeamanuel, A. M. Rapoport & R. P. Cowan. (2014) What Is the Evidence for the Use of Corticosteroids in Migraine?. Current Pain and Headache Reports 18:12.
Crossref
James D. Rose & C. Jeffrey Woodbury. 2008. Sourcebook of Models for Biomedical Research. Sourcebook of Models for Biomedical Research 333 339 .
NM Ramadan, V Skljarevski, LA Phebus & KW Johnson. (2016) 5-HT 1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis . Cephalalgia 23:8, pages 776-785.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.